02/20/2026
🧠What if a breakthrough cancer therapy could also fight Alzheimer’s disease?
In a new study published in PNAS, researchers led by Prof. Ido Amit at the Weizmann Institute of Science adapted CAR T-cell therapy, an immune cell therapy first developed at Weizmann, to target toxic amyloid plaques in the brain. In a mouse model of Alzheimer’s, the engineered cells reduced plaque buildup and brain inflammation.
This research, proudly supported by Canadian philanthropy, opens the door to applying powerful cancer immunotherapies to neurodegenerative diseases.
🔗 Tap the link to read more: https://loom.ly/_O1ffpw